{"gene":"ECE2","run_date":"2026-06-09T23:54:42","timeline":{"discoveries":[{"year":1995,"finding":"ECE-2 is a membrane-bound, phosphoramidon-sensitive zinc metalloprotease that converts big ET-1 to mature ET-1 by cleavage at Trp21-Val22, with an acidic pH optimum of 5.5 (in contrast to ECE-1's neutral optimum). It is inhibited by phosphoramidon (250-fold more sensitive than ECE-1) and FR901533 but not by thiorphan or captopril. Transfection experiments in CHO cells showed it converts endogenously synthesized big ET-1 intracellularly but not exogenous big ET-1, indicating it acts as an intracellular enzyme in the trans-Golgi network.","method":"In vitro enzymatic assay, inhibitor profiling, transfected CHO cell functional assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro biochemical reconstitution plus cell-based functional assay with pharmacological inhibitors; foundational characterization paper replicated by multiple subsequent studies","pmids":["7797512"],"is_preprint":false},{"year":2000,"finding":"ECE-2 knockout mice develop normally and are fertile, but when bred into an ECE-1 null background, cardiac outflow defects are more severe than in ECE-1 single knockouts, and ECE-1−/−;ECE-2−/− double-null embryos exhibit abnormal atrioventricular valve formation not seen in ECE-1 single knockouts. ECE-2 mRNA is expressed in endocardial cushion mesenchyme from E12.5. Together, this establishes ECE-2 has a role in murine cardiac development, particularly in endocardial cushion/valve formation.","method":"Homologous recombination knockout mice, genetic epistasis (double knockout), in situ hybridization, ET-1/ET-2 peptide measurement by immunoassay","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic KO with defined cardiac phenotype, double-mutant epistasis, replicated across multiple embryonic timepoints in a single rigorous study","pmids":["10811845"],"is_preprint":false},{"year":2002,"finding":"ECE-2 deficient mice show significant increases in both Aβ40 and Aβ42 levels in the brain compared to age-matched littermate controls, providing the first direct in vivo evidence that ECE-2 physiologically limits Aβ accumulation in the brain.","method":"ECE-2 knockout mouse model, brain Aβ measurement by ELISA/immunoassay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean knockout mouse with specific biochemical readout (Aβ levels), directly establishing physiological role in Aβ clearance","pmids":["12464614"],"is_preprint":false},{"year":2003,"finding":"Purified recombinant ECE-2 cleaves big ET-1 to ET-1 at Trp21-Val22 at acidic pH and processes a panel of 42 neuropeptides at non-classical (non-basic residue) sites, preferring aliphatic/aromatic residues in the P1' position. ECE-2 processes proenkephalin-derived peptides (bovine adrenal medulla peptides) and PEN-LEN (an endogenous inhibitor of prohormone convertase 1) into products with altered biological activity, indicating a role in non-classical neuropeptide processing.","method":"Purification of recombinant ECE-2, mass spectrometry-based substrate profiling with 42-peptide panel, in vitro enzymatic assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — purified recombinant enzyme reconstitution with mass spectrometry substrate profiling and multiple peptide substrates; rigorous biochemical characterization","pmids":["12560336"],"is_preprint":false},{"year":1999,"finding":"ECE-2 is localized intracellularly (not on the cell surface) in human umbilical vein endothelial cells. Using sucrose density gradient fractionation and pH/inhibitor profiling (sensitivity to 0.1 µM phosphoramidon at pH 5.4, IC50 1.5 nM; insensitive to ECE-1-selective inhibitor PD159790 at pH 5.4), ECE-2 activity was identified in intracellular fractions. Confocal microscopy showed punctate cytosolic staining consistent with secretory vesicles, suggesting a role in processing big ET-1 in transit via the constitutive secretory pathway.","method":"Subcellular fractionation (sucrose density gradient), pH-dependent enzymatic activity assay with selective inhibitors, confocal immunocytochemistry","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — two orthogonal methods (biochemical fractionation + confocal microscopy) in a single study definitively establishing intracellular localization","pmids":["10222335"],"is_preprint":false},{"year":2002,"finding":"Four ECE-2 sub-isoforms (ECE-2a-1, ECE-2a-2, ECE-2b-1, ECE-2b-2) were identified that differ in their N-terminal cytoplasmic tails. RT-PCR showed strikingly different tissue distributions: ECE-2a-1 and ECE-2a-2 are expressed in liver, kidney, adrenal gland, testis, and endothelial cells, while ECE-2b-1 and ECE-2b-2 are enriched in brain and adrenal gland. Immunohistochemical analysis of CHO cells stably expressing ECE-2a-1 or ECE-2b-2 showed both isoforms localize to intracellular compartments, not the cell surface.","method":"RT-PCR, stable transfection of CHO cells, immunohistochemistry","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — single lab with two orthogonal methods (RT-PCR + immunohistochemistry), identifying isoform diversity and intracellular localization","pmids":["12054617"],"is_preprint":false},{"year":2008,"finding":"ECE-2 knockout mice show normal physical appearance and motor behavior but display significant deficits in learning and memory, including impaired performance in the Morris water maze, deficits in object recognition and location memory, and impaired social transmission of food preference. This establishes ECE-2 as required for normal learning and memory function in vivo.","method":"ECE-2 knockout mice, Morris water maze, novel object recognition, social transmission of food preference behavioral assays","journal":"Genes, brain, and behavior","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean knockout mouse model with multiple independent behavioral readouts across different memory paradigms","pmids":["21450041"],"is_preprint":false},{"year":2008,"finding":"ECE-2 homology model based on neprilysin crystal structure was generated, and site-directed mutagenesis identified that Tyr563 in the catalytic site significantly affects catalytic activity and inhibitor binding, while Trp148 mutation had lesser effect. Virtual screening of 13,000 compounds using the model identified three compounds with high affinity and specificity for ECE-2 over neprilysin.","method":"Homology modeling using neprilysin crystal structure as template, site-directed mutagenesis, virtual screening, in vitro enzymatic inhibition assays","journal":"Journal of medicinal chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — structure-based model with mutagenesis validation of active-site residues and functional confirmation via inhibitor assays; single lab but multiple orthogonal methods","pmids":["18507370"],"is_preprint":false},{"year":2013,"finding":"ECE-2 co-localizes with markers of the endosomal/lysosomal pathway (but not with a trans-Golgi network marker) and is detected in autophagic vesicles. Pharmacological inhibition of ECE activity in SH-SY5Y cells overexpressing APP leads to intracellular Aβ accumulation specifically in the endosomal-autophagic-lysosomal compartments. ECE-2 regulates mainly the intracellular pool of Aβ (produced and degraded within the endosomal-autophagic-lysosomal pathways), distinct from ECE-1 which regulates both intracellular and secreted Aβ pools.","method":"Co-localization immunofluorescence microscopy, pharmacological ECE inhibition in APP-overexpressing SH-SY5Y cells, Aβ measurement by ELISA","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (subcellular co-localization + pharmacological inhibition + biochemical Aβ quantification) establishing compartment-specific function","pmids":["23283972"],"is_preprint":false},{"year":2014,"finding":"ECE-2 inhibition with the selective inhibitor S136492 impairs µ opioid receptor recycling and resensitization specifically for ligands that are ECE2 substrates (endogenous opioid peptides), both in heterologous cells and cells endogenously co-expressing µ receptors with ECE2. In vivo, ECE2 inhibition attenuated antinociception mediated only by ECE2-substrate opioid peptides (intrathecal tail-flick assay). This establishes ECE2 as modulating µ opioid receptor function through post-endocytic processing of peptide agonists.","method":"Selective pharmacological ECE2 inhibition, µ opioid receptor trafficking assay (ELISA and microscopy), cAMP signaling assay, in vivo tail-flick antinociception assay","journal":"British journal of pharmacology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (receptor trafficking, cAMP signaling, in vivo behavioral assay) with selective inhibitor and substrate-specificity controls; single lab","pmids":["24990314"],"is_preprint":false},{"year":2014,"finding":"ECE2 inhibition with selective inhibitors impairs δ opioid receptor recycling by protecting endocytosed peptide agonists from degradation, leading to decreased surface receptor signaling. ECE2 co-localizes intracellularly with δ opioid receptors following agonist treatment. In primary neurons, ECE2 inhibitor treatment increased intracellular co-localization of receptors with ECE2 and decreased recycling and surface receptor signaling.","method":"Selective ECE2 inhibitor treatment, δ opioid receptor trafficking assay (microscopy), intracellular peptide degradation assay (thin-layer chromatography), primary neuronal cultures","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods in heterologous and primary neurons establishing post-endocytic peptide processing as mechanism for receptor regulation","pmids":["24847082"],"is_preprint":false},{"year":2010,"finding":"An ECE-2-specific fluorogenic substrate (PL405; Ac-SKG-Pya-F-W-Nop-GGK-NH2) was identified; ECE-2 cleaves PL405 at the Pya-F amide bond with kcat/Km = 8.1 × 10³ M⁻¹ s⁻¹. The first potent and selective ECE-2 inhibitor was characterized (Ki = 7.7 nM). The assay was validated using wild-type and ECE-2 knockout tissues ex vivo, confirming it reflects ECE-2 expression patterns.","method":"Fluorogenic substrate screening (Fluofast library), in vitro enzymatic kinetics, ECE-2 knockout tissue validation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with kinetic characterization and knockout tissue validation as orthogonal control; rigorous biochemical characterization","pmids":["20807771"],"is_preprint":false},{"year":2011,"finding":"ECE-2 knockout mice show decreased antinociceptive response to a single morphine injection and more rapid development of tolerance with prolonged morphine treatment and fewer signs of naloxone-precipitated withdrawal. Peptidomic analysis of spinal cord revealed altered levels of multiple neuropeptides in ECE-2 KO mice compared to wild-type, consistent with ECE-2's role in non-classical in vivo spinal cord neuropeptide processing.","method":"ECE-2 knockout mice, hot-plate and tail-flick pain assays, naloxone-precipitated withdrawal, peptidomic mass spectrometry of spinal cord","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean knockout model with multiple behavioral readouts and peptidomic biochemical analysis establishing in vivo role in neuropeptide processing and morphine responses","pmids":["21972895"],"is_preprint":false},{"year":2016,"finding":"ECE-2 is expressed predominantly in somatostatin-expressing GABAergic interneurons in hippocampus and neocortex (unlike ECE-1, which has broader distribution, and NEP, found in parvalbumin interneurons). ECE-2 was active in isolated synaptosomes, establishing that ECE-2 can degrade Aβ at inhibitory synapses relevant to Alzheimer's disease.","method":"In situ hybridization, immunohistochemistry with cell-type markers, synaptosome isolation and enzymatic activity assay","journal":"Neurobiology of aging","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (ISH, IHC with cell-type markers, functional synaptosome assay) definitively establishing cell-type-specific localization and activity","pmids":["27644077"],"is_preprint":false},{"year":2017,"finding":"ECE-1 and ECE-2 cleave and degrade α-synuclein in vitro. siRNA knockdown of ECE-1 or ECE-2 in SH-SY5Y cells significantly increased α-syn both intracellularly and extracellularly. ECE-2 co-localizes with α-syn within the endolysosomal system (confirmed by proximity ligation assay). ECE-2 levels are significantly reduced in postmortem cingulate cortex of dementia with Lewy bodies (DLB) patients and inversely correlate with severity of Lewy body pathology (α-syn phosphorylated at Ser129).","method":"In vitro enzymatic cleavage assay, siRNA knockdown, double immunofluorescence, proximity ligation assay, sandwich ELISA on postmortem tissue","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (in vitro assay, siRNA KD, co-localization, PLA, human tissue quantification) establishing ECE-2 as an α-syn degrading enzyme","pmids":["28171705"],"is_preprint":false},{"year":2017,"finding":"CRISPR-mediated inactivation of ECE2 (the synthetic enzyme for EDN3) from the zebrafish microenvironment abrogates melanoma phenotype switching from invasive/MITF-low to proliferative/MITF-high state following extravasation, and increases animal survival. This establishes ECE2 as required for microenvironment-driven endothelin-3 production that promotes melanoma metastatic plasticity.","method":"CRISPR-mediated gene inactivation in zebrafish, live zebrafish imaging, melanoma phenotype switching assay","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — CRISPR loss-of-function with defined phenotypic readout (phenotype switching, survival) in an in vivo vertebrate model","pmids":["28181494"],"is_preprint":false},{"year":2014,"finding":"Zebrafish karneol (kar) mutant, defective in ece2, displays reduced iridophore numbers and defects in adult pigment stripe patterning. Morpholino knockdown identified Endothelin 3b (Edn3b) as the ligand for endothelin receptor signaling in larval iridophores processed by Ece2, establishing that Ece2-mediated proteolytic activation of endothelin ligands is required for iridophore development and melanophore maintenance in zebrafish.","method":"Zebrafish forward genetics (kar mutant), morpholino-mediated knockdown, genetic rescue","journal":"Biology open","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo genetic loss-of-function (mutant + morpholino) with defined cellular phenotype, identifying substrate ligand","pmids":["24857848"],"is_preprint":false},{"year":2020,"finding":"ECE2 rare coding variants (R186C and F751S) located in the peptidase domain severely impair ECE2 enzymatic activity in Aβ degradation. Overexpression of wild-type ECE2 in the hippocampus of APP-knockin AD model mice reduced amyloid load, plaque formation, and improved learning and memory deficits, but the R186C mutant abolished these effects, directly linking ECE2 catalytic activity to Aβ clearance and AD-relevant phenotypes in vivo.","method":"Rare variant identification, in vitro enzymatic activity assay with Aβ substrate, stereotaxic AAV-mediated ECE2/R186C overexpression in APP-knockin mice, amyloid quantification, Morris water maze","journal":"JCI insight","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — mutagenesis establishing catalytic residue requirement, complemented by in vivo gene therapy with wild-type vs. mutant rescue in AD model mice","pmids":["32102983"],"is_preprint":false},{"year":2020,"finding":"Manipulation of ECE2 levels in human cerebral organoids and in the developing mouse cortex leads to ectopic localization of neural progenitors and neurons. ECE2 is required for normal neurogenesis and neuronal migration during cortical development, and mechanistically is involved in the generation and secretion of extracellular matrix proteins as well as cytoskeleton and adhesion processes. Biallelic ECE2 variants were identified in patients with periventricular heterotopia.","method":"Human cerebral organoids (ECE2 manipulation), in utero electroporation in developing mouse cortex, proteomic/secretome analysis, immunostaining for ECE2","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function in two independent experimental systems (organoids + mouse cortex) with defined cellular phenotype and mechanistic follow-up (ECM proteins, cytoskeleton)","pmids":["32207244"],"is_preprint":false},{"year":2025,"finding":"ECE2 and κ opioid receptor (KOR) are in close proximity (demonstrated by proximity ligation assay) and co-internalize following activation by prodynorphin/proenkephalin-derived peptide substrates. ECE2 inhibition significantly attenuates KOR recycling and resensitization specifically for peptides that are ECE2 substrates but not for non-substrate peptides, establishing that ECE2 post-endocytically processes opioid peptides to regulate KOR trafficking and signaling.","method":"Proximity ligation assay, receptor internalization/recycling assay in recombinant and endogenously expressing cells, small molecule ECE2 inhibitor, cAMP signaling assay","journal":"The Journal of pharmacology and experimental therapeutics","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (PLA, trafficking assays, signaling assays) in recombinant and endogenous cell systems with substrate-specificity controls; single lab","pmids":["41205376"],"is_preprint":false},{"year":2009,"finding":"ECE-2 mRNA and protein are markedly elevated in postmortem temporal cortex in Alzheimer's disease (AD) but not in vascular dementia. Exposure of SH-SY5Y cells to monomeric or oligomeric Aβ(1-42) caused an initial decrease in ECE-2 mRNA at 4 hours followed by a marked increase by 24 hours, demonstrating that Aβ42 upregulates ECE-2 expression.","method":"Quantitative real-time PCR, sandwich ELISA on postmortem brain tissue, Aβ42 treatment of SH-SY5Y cells with ECE-2 mRNA measurement","journal":"The American journal of pathology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — postmortem tissue quantification and in vitro stimulation assay; two methods but no direct mechanistic pathway dissection","pmids":["19541930"],"is_preprint":false},{"year":2008,"finding":"ECE-1, but not ECE-2, cleaved somatostatin-14 (SST-14) in an acidic endosomal environment; ECE-2 did not hydrolyze SST-14 or octreotide. This negative result establishes substrate specificity boundaries: SST-14 is not an ECE-2 substrate.","method":"Pharmacological inhibition of ECE-1 with SM-19712, bafilomycin A1 to prevent endosomal acidification, radiolabeled substrate degradation assay","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single lab with direct in vitro substrate assay; this is a negative result establishing substrate specificity","pmids":["18276747"],"is_preprint":false}],"current_model":"ECE-2 is an intracellularly localized (trans-Golgi/endosomal-lysosomal compartments), acidic pH-optimum (pH 5.5), phosphoramidon-sensitive zinc metalloprotease of the M13/neprilysin family that converts big endothelin to ET-1 intracellularly, processes neuropeptides at non-classical cleavage sites, degrades Aβ peptide and α-synuclein within endosomal-autophagic-lysosomal pathways, and regulates µ, δ, and κ opioid receptor recycling and resensitization by post-endocytic hydrolysis of co-internalized peptide agonists; it is also required for normal cardiac development, neuronal migration/neurogenesis in the cortex, learning and memory, and spinal cord neuropeptide homeostasis, with its Aβ-degrading catalytic activity directly linked to Alzheimer's disease risk."},"narrative":{"mechanistic_narrative":"ECE2 is an intracellular, acidic-pH-optimum (pH 5.5), phosphoramidon-sensitive zinc metalloprotease of the neprilysin-related family that processes endothelin precursors and a broad set of neuropeptides at non-classical cleavage sites within secretory and endolysosomal compartments [PMID:7797512, PMID:12560336, PMID:10222335]. It converts big ET-1 to mature ET-1 by cleavage at Trp21-Val22 intracellularly rather than at the cell surface, and exists as multiple N-terminally distinct sub-isoforms with tissue-specific distributions that all localize to intracellular compartments [PMID:7797512, PMID:10222335, PMID:12054617]. A neprilysin-based homology model and site-directed mutagenesis identify Tyr563 as a catalytic-site residue critical for activity and inhibitor binding [PMID:18507370]. ECE2 resides in endosomal/lysosomal and autophagic vesicles, where it degrades intracellular pools of the amyloid-β peptide and α-synuclein; loss of ECE2 raises brain Aβ40 and Aβ42 and elevates α-synuclein, and ECE2 is dysregulated in Alzheimer's disease and dementia-with-Lewy-bodies brain tissue [PMID:12464614, PMID:23283972, PMID:28171705, PMID:19541930]. In the nervous system ECE2 is enriched in somatostatin-expressing GABAergic interneurons and acts at synapses, shaping spinal-cord neuropeptide content and supporting learning and memory [PMID:21450041, PMID:21972895, PMID:27644077]. Through post-endocytic hydrolysis of co-internalized peptide agonists, ECE2 regulates the recycling and resensitization of µ, δ, and κ opioid receptors in a substrate-specific manner, influencing opioid antinociception and morphine tolerance in vivo [PMID:24990314, PMID:24847082, PMID:21972895, PMID:41205376]. ECE2 is also required for endothelin-ligand activation driving cardiac endocardial cushion/valve development, pigment-cell development, melanoma phenotype switching, and cortical neurogenesis and neuronal migration, the last linked to periventricular heterotopia caused by biallelic ECE2 variants [PMID:10811845, PMID:28181494, PMID:24857848, PMID:32207244]. Rare peptidase-domain coding variants that impair Aβ-degrading activity, together with rescue of amyloid load and memory deficits by wild-type but not catalytically defective ECE2 in AD model mice, directly link ECE2 catalytic activity to Alzheimer's disease risk [PMID:32102983].","teleology":[{"year":1995,"claim":"Established ECE2 as a distinct endothelin-converting enzyme by showing it cleaves big ET-1 to ET-1 with an acidic pH optimum and acts intracellularly, distinguishing it from the neutral-pH, surface-acting ECE-1.","evidence":"In vitro enzymatic assay with inhibitor profiling and transfected CHO cell functional assay","pmids":["7797512"],"confidence":"High","gaps":["Did not define the physiological compartment beyond trans-Golgi inference","Full substrate repertoire beyond big ET-1 unknown at this stage"]},{"year":1999,"claim":"Resolved where ECE2 acts by demonstrating it is intracellular rather than cell-surface, supporting a role in processing big ET-1 in transit through the secretory pathway.","evidence":"Sucrose-gradient subcellular fractionation, pH/inhibitor activity profiling, and confocal immunocytochemistry in HUVECs","pmids":["10222335"],"confidence":"High","gaps":["Did not distinguish secretory vesicle from endosomal/lysosomal residence","Did not address non-endothelin substrates"]},{"year":2000,"claim":"Defined an in vivo developmental role by showing ECE2 contributes to cardiac endocardial cushion and valve formation, unmasked in the ECE-1 null background.","evidence":"Single and double knockout mice with genetic epistasis, in situ hybridization, and ET peptide immunoassay","pmids":["10811845"],"confidence":"High","gaps":["ECE2 single knockouts are normal, leaving its independent requirement unclear","Molecular substrate driving the valve phenotype not pinpointed"]},{"year":2002,"claim":"Extended ECE2 function beyond endothelins by showing it physiologically limits brain Aβ accumulation and exists as tissue-specific sub-isoforms.","evidence":"Knockout mouse brain Aβ ELISA; RT-PCR and immunohistochemistry of isoforms in transfected cells","pmids":["12464614","12054617"],"confidence":"High","gaps":["Direct enzymatic degradation of Aβ not yet shown","Functional consequence of isoform diversity unresolved"]},{"year":2003,"claim":"Characterized ECE2 as a non-classical neuropeptide-processing protease, cleaving at aliphatic/aromatic P1' residues across a 42-peptide panel including enkephalin-derived peptides and PEN-LEN.","evidence":"Purified recombinant enzyme with mass spectrometry-based substrate profiling","pmids":["12560336"],"confidence":"High","gaps":["Which substrates are processed in vivo not established","Biological significance of altered peptide products not tested"]},{"year":2008,"claim":"Provided a structural and behavioral framework: an active-site model identified Tyr563 as catalytically important and selective inhibitors were derived, while knockout mice revealed learning and memory deficits; substrate boundaries were refined by showing somatostatin-14 is not a substrate.","evidence":"Neprilysin-based homology modeling with mutagenesis and virtual screening; behavioral testing of knockout mice; in vitro substrate assays with bafilomycin/SM-19712","pmids":["18507370","21450041","18276747"],"confidence":"High","gaps":["No experimental crystal structure of ECE2","Molecular substrate linking ECE2 to memory not identified","SST-14 negative result limited to in vitro conditions"]},{"year":2010,"claim":"Built a selective toolkit by identifying an ECE2-specific fluorogenic substrate and a potent selective inhibitor, validated against knockout tissue.","evidence":"Fluorogenic substrate screening with kinetic characterization and ECE2 knockout tissue validation","pmids":["20807771"],"confidence":"High","gaps":["Synthetic substrate does not identify endogenous physiological substrates","Inhibitor specificity in complex tissue not exhaustively profiled"]},{"year":2011,"claim":"Connected ECE2 to opioid pharmacology and in vivo neuropeptide homeostasis by showing knockouts have altered morphine responses and a shifted spinal-cord peptidome.","evidence":"Knockout mice with pain/tolerance/withdrawal assays and spinal-cord peptidomic mass spectrometry","pmids":["21972895"],"confidence":"High","gaps":["Causal peptide substrates underlying morphine phenotypes not isolated","Did not separate direct opioid-peptide processing from broader peptidome changes"]},{"year":2013,"claim":"Refined ECE2's compartment to the endosomal-autophagic-lysosomal system, establishing it controls the intracellular Aβ pool distinct from ECE-1's broader action.","evidence":"Co-localization microscopy and pharmacological ECE inhibition in APP-overexpressing SH-SY5Y cells with Aβ ELISA","pmids":["23283972"],"confidence":"High","gaps":["Pharmacological inhibition does not isolate ECE2 from ECE-1","Mechanism of Aβ entry into the degradative compartment not defined"]},{"year":2014,"claim":"Defined the mechanism of opioid receptor regulation as post-endocytic hydrolysis of co-internalized peptide agonists, controlling µ and δ receptor recycling and resensitization in a substrate-specific manner.","evidence":"Selective ECE2 inhibitors, receptor trafficking and cAMP assays, intracellular peptide degradation assays, primary neurons, and in vivo antinociception","pmids":["24990314","24847082"],"confidence":"High","gaps":["Relied on pharmacological inhibition rather than genetic ablation in trafficking assays","Structural basis of ECE2-receptor proximity not resolved"]},{"year":2014,"claim":"Established that ECE2-mediated endothelin-ligand activation is required for pigment-cell development, identifying Edn3b as a processed ligand.","evidence":"Zebrafish forward genetics (kar mutant), morpholino knockdown, and genetic rescue","pmids":["24857848"],"confidence":"High","gaps":["Direct biochemical cleavage of Edn3b by Ece2 not shown in this system","Relevance to mammalian pigment biology not addressed"]},{"year":2016,"claim":"Pinpointed the cellular source of ECE2 in the brain to somatostatin-expressing GABAergic interneurons and showed it is active at synapses, defining a cell-type context for Aβ degradation.","evidence":"In situ hybridization, cell-type-marker immunohistochemistry, and synaptosome enzymatic activity assays","pmids":["27644077"],"confidence":"High","gaps":["Functional consequence of interneuron-specific Aβ degradation not tested","Did not establish synaptic substrate specificity"]},{"year":2017,"claim":"Broadened ECE2's degradative role to α-synuclein within the endolysosomal system and linked reduced ECE2 to Lewy body pathology; in cancer, ECE2-driven endothelin-3 production was shown to enable melanoma phenotype switching and metastasis.","evidence":"In vitro cleavage, siRNA knockdown, PLA co-localization, and postmortem ELISA for α-syn; CRISPR inactivation with live imaging in zebrafish melanoma","pmids":["28171705","28181494"],"confidence":"High","gaps":["Whether ECE2 loss is cause or consequence of DLB pathology unresolved","Direct endothelin substrate in melanoma microenvironment not biochemically isolated"]},{"year":2020,"claim":"Causally tied ECE2 catalytic activity to Alzheimer's disease and identified a developmental neuronal-migration role, providing direct genetic links to human disease.","evidence":"Rare-variant identification with enzymatic assays and AAV wild-type vs. R186C rescue in APP-knockin mice; ECE2 manipulation in cerebral organoids and in utero electroporation with secretome proteomics, plus biallelic variants in periventricular heterotopia","pmids":["32102983","32207244"],"confidence":"High","gaps":["Mechanism linking ECM/cytoskeleton effects to migration not fully dissected","Penetrance and full genetic spectrum of human variants not defined"]},{"year":2025,"claim":"Completed the opioid receptor regulatory model by showing ECE2 also controls κ opioid receptor trafficking through substrate-specific post-endocytic peptide processing.","evidence":"Proximity ligation assay, receptor internalization/recycling and cAMP assays with substrate-specificity controls in recombinant and endogenous cells","pmids":["41205376"],"confidence":"High","gaps":["Single-lab pharmacological approach without genetic confirmation","In vivo consequences of KOR regulation not tested"]},{"year":null,"claim":"How ECE2's distinct functions — endothelin maturation, neuropeptide processing, Aβ/α-synuclein degradation, opioid receptor regulation, and cortical development — are partitioned across its sub-isoforms and subcellular compartments, and which substrates drive each in vivo phenotype, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No experimental structure of ECE2","Isoform-specific functional assignments not established","Substrate-to-phenotype causality not mapped for most in vivo roles"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,3,7,11,14,17]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,3,17]}],"localization":[{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[8,10,14]},{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[8,14]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[0,4]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[4,8]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,3,17]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[9,10,19]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[1,16,18]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[2,14,17]}],"complexes":[],"partners":["OPRM1","OPRD1","OPRK1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P0DPD6","full_name":"Endothelin-converting enzyme 2","aliases":[],"length_aa":811,"mass_kda":91.2,"function":"Converts big endothelin-1 to endothelin-1. Also involved in the processing of various neuroendocrine peptides, including neurotensin, angiotensin I, substance P, proenkephalin-derived peptides, and prodynorphin-derived peptides. May play a role in amyloid-beta processing (By similarity)","subcellular_location":"Golgi apparatus membrane; Cytoplasmic vesicle, secretory vesicle membrane","url":"https://www.uniprot.org/uniprotkb/P0DPD6/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ECE2","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":383,"dependency_fraction":0.0026109660574412533},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ECE2","total_profiled":1310},"omim":[{"mim_id":"610145","title":"ENDOTHELIN-CONVERTING ENZYME 2; ECE2","url":"https://www.omim.org/entry/610145"},{"mim_id":"600423","title":"ENDOTHELIN-CONVERTING ENZYME 1; ECE1","url":"https://www.omim.org/entry/600423"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":58.1},{"tissue":"pancreas","ntpm":24.1},{"tissue":"pituitary gland","ntpm":19.1}],"url":"https://www.proteinatlas.org/search/ECE2"},"hgnc":{"alias_symbol":["KIAA0604","MGC2408"],"prev_symbol":[]},"alphafold":{"accession":"P0DPD6","domains":[{"cath_id":"3.40.390.10","chopping":"144-178_498-549_604-795","consensus_level":"high","plddt":96.3638,"start":144,"end":795},{"cath_id":"1.10.1380.10","chopping":"242-447","consensus_level":"high","plddt":95.8638,"start":242,"end":447}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P0DPD6","model_url":"https://alphafold.ebi.ac.uk/files/AF-P0DPD6-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P0DPD6-F1-predicted_aligned_error_v6.png","plddt_mean":87.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ECE2","jax_strain_url":"https://www.jax.org/strain/search?query=ECE2"},"sequence":{"accession":"P0DPD6","fasta_url":"https://rest.uniprot.org/uniprotkb/P0DPD6.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P0DPD6/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P0DPD6"}},"corpus_meta":[{"pmid":"7797512","id":"PMC_7797512","title":"Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7797512","citation_count":391,"is_preprint":false},{"pmid":"25526346","id":"PMC_25526346","title":"Mutational landscape of intrahepatic cholangiocarcinoma.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25526346","citation_count":353,"is_preprint":false},{"pmid":"9141502","id":"PMC_9141502","title":"Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX.","date":"1997","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/9141502","citation_count":344,"is_preprint":false},{"pmid":"11223883","id":"PMC_11223883","title":"The neprilysin (NEP) family of zinc metalloendopeptidases: genomics and function.","date":"2001","source":"BioEssays : news and reviews in molecular, cellular and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/11223883","citation_count":334,"is_preprint":false},{"pmid":"18363935","id":"PMC_18363935","title":"Abeta-degrading enzymes in Alzheimer's disease.","date":"2008","source":"Brain pathology (Zurich, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/18363935","citation_count":330,"is_preprint":false},{"pmid":"12464614","id":"PMC_12464614","title":"Alzheimer's disease beta-amyloid peptide is increased in mice deficient in endothelin-converting enzyme.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12464614","citation_count":217,"is_preprint":false},{"pmid":"8615890","id":"PMC_8615890","title":"Molecular pharmacology of endothelin converting enzymes.","date":"1996","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/8615890","citation_count":200,"is_preprint":false},{"pmid":"8530372","id":"PMC_8530372","title":"Organization of the gene encoding the human endothelin-converting enzyme (ECE-1).","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8530372","citation_count":186,"is_preprint":false},{"pmid":"16246055","id":"PMC_16246055","title":"Abeta-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention.","date":"2005","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/16246055","citation_count":180,"is_preprint":false},{"pmid":"10811845","id":"PMC_10811845","title":"Disruption of ECE-1 and ECE-2 reveals a role for endothelin-converting enzyme-2 in murine cardiac development.","date":"2000","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/10811845","citation_count":149,"is_preprint":false},{"pmid":"28181494","id":"PMC_28181494","title":"Microenvironment-derived factors driving metastatic plasticity in melanoma.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28181494","citation_count":120,"is_preprint":false},{"pmid":"22330820","id":"PMC_22330820","title":"Endothelin-1 is elevated in Alzheimer's disease and upregulated by amyloid-β.","date":"2012","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/22330820","citation_count":107,"is_preprint":false},{"pmid":"26452729","id":"PMC_26452729","title":"Pathophysiology of Hypoperfusion of the Precuneus in Early Alzheimer's Disease.","date":"2015","source":"Brain pathology (Zurich, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/26452729","citation_count":100,"is_preprint":false},{"pmid":"19541930","id":"PMC_19541930","title":"Endothelin-converting enzyme-2 is increased in Alzheimer's disease and up-regulated by Abeta.","date":"2009","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/19541930","citation_count":96,"is_preprint":false},{"pmid":"21826742","id":"PMC_21826742","title":"Multiple cellular and molecular mechanisms are involved in human Aβ clearance by transplanted adult astrocytes.","date":"2011","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/21826742","citation_count":82,"is_preprint":false},{"pmid":"16999223","id":"PMC_16999223","title":"Endothelin.","date":"2006","source":"Handbook of experimental pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16999223","citation_count":74,"is_preprint":false},{"pmid":"24378671","id":"PMC_24378671","title":"The profibrotic role of endothelin-1: is the door still open for the treatment of fibrotic diseases?","date":"2013","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/24378671","citation_count":74,"is_preprint":false},{"pmid":"23283972","id":"PMC_23283972","title":"Endothelin-converting enzymes degrade intracellular β-amyloid produced within the endosomal/lysosomal pathway and autophagosomes.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23283972","citation_count":71,"is_preprint":false},{"pmid":"12839262","id":"PMC_12839262","title":"Synthesis and degradation of endothelin-1.","date":"2003","source":"Canadian journal of physiology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12839262","citation_count":68,"is_preprint":false},{"pmid":"10749671","id":"PMC_10749671","title":"Molecular cloning and biochemical characterization of a new mouse testis soluble-zinc-metallopeptidase of the neprilysin family.","date":"2000","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/10749671","citation_count":66,"is_preprint":false},{"pmid":"29085811","id":"PMC_29085811","title":"Alizarin and Chrysazin Inhibit Biofilm and Hyphal Formation by Candida albicans.","date":"2017","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/29085811","citation_count":62,"is_preprint":false},{"pmid":"9654154","id":"PMC_9654154","title":"Purification of a novel endothelin-converting enzyme specific for big endothelin-3.","date":"1998","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9654154","citation_count":60,"is_preprint":false},{"pmid":"23629587","id":"PMC_23629587","title":"Endothelin-converting enzyme-1 activity, endothelin-1 production, and free radical-dependent vasoconstriction in Alzheimer's disease.","date":"2013","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/23629587","citation_count":56,"is_preprint":false},{"pmid":"8880948","id":"PMC_8880948","title":"The endothelins in the pulmonary system.","date":"1996","source":"Pulmonary pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/8880948","citation_count":53,"is_preprint":false},{"pmid":"10849750","id":"PMC_10849750","title":"The neprilysin family in health and disease.","date":"2000","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/10849750","citation_count":52,"is_preprint":false},{"pmid":"21193044","id":"PMC_21193044","title":"Endothelin receptor antagonists: potential in Alzheimer's disease.","date":"2010","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/21193044","citation_count":49,"is_preprint":false},{"pmid":"9253714","id":"PMC_9253714","title":"Evidence of alternative promoters directing isoform-specific expression of human endothelin-converting enzyme-1 mRNA in cultured endothelial cells.","date":"1997","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/9253714","citation_count":49,"is_preprint":false},{"pmid":"32207244","id":"PMC_32207244","title":"ECE2 regulates neurogenesis and neuronal migration during human cortical development.","date":"2020","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/32207244","citation_count":48,"is_preprint":false},{"pmid":"28824600","id":"PMC_28824600","title":"Antibiofilm and Antihyphal Activities of Cedar Leaf Essential Oil, Camphor, and Fenchone Derivatives against Candida albicans.","date":"2017","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/28824600","citation_count":48,"is_preprint":false},{"pmid":"20143331","id":"PMC_20143331","title":"Transdifferentiation potentiality of human Wharton's jelly stem cells towards vascular endothelial cells.","date":"2010","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20143331","citation_count":47,"is_preprint":false},{"pmid":"21406445","id":"PMC_21406445","title":"Expression pattern of endothelin system components and localization of smooth muscle cells in the human pre-ovulatory follicle.","date":"2011","source":"Human reproduction (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21406445","citation_count":45,"is_preprint":false},{"pmid":"16567585","id":"PMC_16567585","title":"Polymorphism in endothelin-related genes limits exercise-induced decreases in arterial stiffness in older subjects.","date":"2006","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/16567585","citation_count":45,"is_preprint":false},{"pmid":"24857848","id":"PMC_24857848","title":"Endothelin signalling in iridophore development and stripe pattern formation of zebrafish.","date":"2014","source":"Biology open","url":"https://pubmed.ncbi.nlm.nih.gov/24857848","citation_count":45,"is_preprint":false},{"pmid":"9239759","id":"PMC_9239759","title":"The endothelin system and endothelin-converting enzyme in the brain: molecular and cellular studies.","date":"1997","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/9239759","citation_count":44,"is_preprint":false},{"pmid":"26293844","id":"PMC_26293844","title":"Inter- and intra-observer variability in the classification of extracapsular extension in p16 positive oropharyngeal squamous cell carcinoma nodal metastases.","date":"2015","source":"Oral oncology","url":"https://pubmed.ncbi.nlm.nih.gov/26293844","citation_count":44,"is_preprint":false},{"pmid":"12560336","id":"PMC_12560336","title":"Characterization of endothelin-converting enzyme-2. Implication for a role in the nonclassical processing of regulatory peptides.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12560336","citation_count":43,"is_preprint":false},{"pmid":"21450041","id":"PMC_21450041","title":"Animals lacking endothelin-converting enzyme-2 are deficient in learning and memory.","date":"2008","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/21450041","citation_count":39,"is_preprint":false},{"pmid":"15863261","id":"PMC_15863261","title":"Endothelins in breast tumour cell invasion.","date":"2005","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/15863261","citation_count":37,"is_preprint":false},{"pmid":"17525706","id":"PMC_17525706","title":"Association of single nucleotide polymorphisms in endothelin family genes with the progression of atherosclerosis in patients with essential hypertension.","date":"2007","source":"Journal of human hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/17525706","citation_count":36,"is_preprint":false},{"pmid":"9808768","id":"PMC_9808768","title":"Soluble human endothelin-converting enzyme-1: expression, purification, and demonstration of pronounced pH sensitivity.","date":"1998","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/9808768","citation_count":33,"is_preprint":false},{"pmid":"20345647","id":"PMC_20345647","title":"Endothelin-converting enzyme-1 in Alzheimer's disease and vascular dementia.","date":"2010","source":"Neuropathology and applied neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/20345647","citation_count":32,"is_preprint":false},{"pmid":"15139053","id":"PMC_15139053","title":"Endothelin axis expression is markedly different in the two main subtypes of renal cell carcinoma.","date":"2004","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15139053","citation_count":32,"is_preprint":false},{"pmid":"20450830","id":"PMC_20450830","title":"Production and binding of endothelin-2 (EDN2) in the rat ovary: endothelin receptor subtype A (EDNRA)-mediated contraction.","date":"2010","source":"Reproduction, fertility, and development","url":"https://pubmed.ncbi.nlm.nih.gov/20450830","citation_count":31,"is_preprint":false},{"pmid":"18276747","id":"PMC_18276747","title":"Endothelin-converting enzyme-1 degrades internalized somatostatin-14.","date":"2008","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/18276747","citation_count":29,"is_preprint":false},{"pmid":"10352019","id":"PMC_10352019","title":"Cyclic expression of endothelin-converting enzyme-1 mediates the functional regulation of seminiferous tubule contraction.","date":"1999","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10352019","citation_count":29,"is_preprint":false},{"pmid":"10222335","id":"PMC_10222335","title":"Evidence for intracellular endothelin-converting enzyme-2 expression in cultured human vascular endothelial cells.","date":"1999","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/10222335","citation_count":29,"is_preprint":false},{"pmid":"27644077","id":"PMC_27644077","title":"Major amyloid-β-degrading enzymes, endothelin-converting enzyme-2 and neprilysin, are expressed by distinct populations of GABAergic interneurons in hippocampus and neocortex.","date":"2016","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/27644077","citation_count":28,"is_preprint":false},{"pmid":"9595395","id":"PMC_9595395","title":"Physiologic shear stress suppresses endothelin-converting enzyme-1 expression in vascular endothelial cells.","date":"1998","source":"Journal of cardiovascular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/9595395","citation_count":27,"is_preprint":false},{"pmid":"11078325","id":"PMC_11078325","title":"Inhibitor potencies and substrate preference for endothelin-converting enzyme-1 are dramatically affected by pH.","date":"2000","source":"Journal of cardiovascular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/11078325","citation_count":26,"is_preprint":false},{"pmid":"11078322","id":"PMC_11078322","title":"Cellular expression of isoforms of endothelin-converting enzyme-1 (ECE-1c, ECE-1b and ECE-1a) and endothelin-converting enzyme-2.","date":"2000","source":"Journal of cardiovascular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/11078322","citation_count":24,"is_preprint":false},{"pmid":"32102983","id":"PMC_32102983","title":"Identification of Alzheimer's disease-associated rare coding variants in the ECE2 gene.","date":"2020","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/32102983","citation_count":22,"is_preprint":false},{"pmid":"12054617","id":"PMC_12054617","title":"Molecular isolation and characterization of novel four subisoforms of ECE-2.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12054617","citation_count":22,"is_preprint":false},{"pmid":"24990314","id":"PMC_24990314","title":"Endothelin-converting enzyme 2 differentially regulates opioid receptor activity.","date":"2014","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24990314","citation_count":22,"is_preprint":false},{"pmid":"31793401","id":"PMC_31793401","title":"Differential DNA methylation following chemotherapy for breast cancer is associated with lack of memory improvement at one year.","date":"2019","source":"Epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/31793401","citation_count":22,"is_preprint":false},{"pmid":"11718899","id":"PMC_11718899","title":"Human endothelin converting enzyme-2 (ECE2): characterization of mRNA species and chromosomal localization.","date":"2001","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/11718899","citation_count":21,"is_preprint":false},{"pmid":"16009335","id":"PMC_16009335","title":"Endothelin inhibition delays onset of hyperglycemia and associated vascular injury in type I diabetes: evidence for endothelin release by pancreatic islet beta-cells.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16009335","citation_count":21,"is_preprint":false},{"pmid":"24847082","id":"PMC_24847082","title":"Opioid receptor function is regulated by post-endocytic peptide processing.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24847082","citation_count":19,"is_preprint":false},{"pmid":"19258203","id":"PMC_19258203","title":"Pathophysiology of the endothelin system - lessons from genetically manipulated animal models.","date":"2009","source":"European journal of medical research","url":"https://pubmed.ncbi.nlm.nih.gov/19258203","citation_count":16,"is_preprint":false},{"pmid":"27058532","id":"PMC_27058532","title":"Genome-Wide Mapping of Growth-Related Quantitative Trait Loci in Orange-Spotted Grouper (Epinephelus coioides) Using Double Digest Restriction-Site Associated DNA Sequencing (ddRADseq).","date":"2016","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27058532","citation_count":16,"is_preprint":false},{"pmid":"9595389","id":"PMC_9595389","title":"Endothelin peptide and converting enzymes in human endothelium.","date":"1998","source":"Journal of cardiovascular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/9595389","citation_count":15,"is_preprint":false},{"pmid":"18507370","id":"PMC_18507370","title":"Homology modeling and site-directed mutagenesis to identify selective inhibitors of endothelin-converting enzyme-2.","date":"2008","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18507370","citation_count":14,"is_preprint":false},{"pmid":"26880534","id":"PMC_26880534","title":"GPER is required for the age-dependent upregulation of the myocardial endothelin system.","date":"2016","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26880534","citation_count":13,"is_preprint":false},{"pmid":"22027013","id":"PMC_22027013","title":"Genetic analysis of genes involved in amyloid-β degradation and clearance in Alzheimer's disease.","date":"2012","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/22027013","citation_count":12,"is_preprint":false},{"pmid":"20844914","id":"PMC_20844914","title":"Transferase activity function and system development process are critical in cattle embryo development.","date":"2010","source":"Functional & integrative genomics","url":"https://pubmed.ncbi.nlm.nih.gov/20844914","citation_count":11,"is_preprint":false},{"pmid":"34392169","id":"PMC_34392169","title":"Identification of novel candidate genes for age at first calving in Nellore cows using a SNP chip specifically developed for Bos taurus indicus cattle.","date":"2021","source":"Theriogenology","url":"https://pubmed.ncbi.nlm.nih.gov/34392169","citation_count":11,"is_preprint":false},{"pmid":"21972895","id":"PMC_21972895","title":"Mice deficient in endothelin-converting enzyme-2 exhibit abnormal responses to morphine and altered peptide levels in the spinal cord.","date":"2011","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21972895","citation_count":11,"is_preprint":false},{"pmid":"16117692","id":"PMC_16117692","title":"Localization of endothelin-converting enzyme in bovine optic nerve and retina.","date":"2005","source":"Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/16117692","citation_count":10,"is_preprint":false},{"pmid":"28253288","id":"PMC_28253288","title":"A novel TCF7L2 type 2 diabetes SNP identified from fine mapping in African American women.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28253288","citation_count":10,"is_preprint":false},{"pmid":"22693153","id":"PMC_22693153","title":"The role of ECE1 variants in cognitive ability in old age and Alzheimer's disease risk.","date":"2012","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22693153","citation_count":9,"is_preprint":false},{"pmid":"25370848","id":"PMC_25370848","title":"Endothelin as a local regulating factor in the bovine oviduct.","date":"2016","source":"Reproduction, fertility, and development","url":"https://pubmed.ncbi.nlm.nih.gov/25370848","citation_count":8,"is_preprint":false},{"pmid":"32279433","id":"PMC_32279433","title":"Ligand-specific recycling profiles determine distinct potential for chronic analgesic tolerance of delta-opioid receptor (DOPr) agonists.","date":"2020","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32279433","citation_count":8,"is_preprint":false},{"pmid":"25085204","id":"PMC_25085204","title":"Endothelin and vascular remodelling in colitis pathogenesis--appendicitis and appendectomy limit colitis by suppressing endothelin pathways.","date":"2014","source":"International journal of colorectal disease","url":"https://pubmed.ncbi.nlm.nih.gov/25085204","citation_count":8,"is_preprint":false},{"pmid":"15544567","id":"PMC_15544567","title":"Endothelin converting enzyme-2: a processing enzyme involved in the generation of novel neuropeptides.","date":"2004","source":"Protein and peptide letters","url":"https://pubmed.ncbi.nlm.nih.gov/15544567","citation_count":8,"is_preprint":false},{"pmid":"36864456","id":"PMC_36864456","title":"SNHG15 enhances cisplatin resistance in lung adenocarcinoma by affecting the DNA repair capacity of cancer cells.","date":"2023","source":"Diagnostic pathology","url":"https://pubmed.ncbi.nlm.nih.gov/36864456","citation_count":7,"is_preprint":false},{"pmid":"16741043","id":"PMC_16741043","title":"Downregulation of renal endothelin-converting enzyme 2 expression in early autoimmune diabetes.","date":"2006","source":"Experimental biology and medicine (Maywood, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/16741043","citation_count":7,"is_preprint":false},{"pmid":"22200003","id":"PMC_22200003","title":"The influence of tumour necrosis factor- α (TNF-α) on amyloid-β (Aβ)-degrading enzymes in vitro.","date":"2011","source":"International journal of molecular epidemiology and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22200003","citation_count":7,"is_preprint":false},{"pmid":"28171705","id":"PMC_28171705","title":"Endothelin-converting enzymes degrade α-synuclein and are reduced in dementia with Lewy bodies.","date":"2017","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28171705","citation_count":6,"is_preprint":false},{"pmid":"20807771","id":"PMC_20807771","title":"Identification of an endothelin-converting enzyme-2-specific fluorigenic substrate and development of an in vitro and ex vivo enzymatic assay.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20807771","citation_count":6,"is_preprint":false},{"pmid":"37483091","id":"PMC_37483091","title":"Anisomycin inhibits the activity of human ovarian cancer stem cells via regulating antisense RNA NCBP2-AS2/MEK/ERK/STAT3 signaling.","date":"2023","source":"The journal of gene medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37483091","citation_count":4,"is_preprint":false},{"pmid":"25517973","id":"PMC_25517973","title":"Transcriptional alterations of ET-1 axis and DNA damage in lung tissue of a rat obesity model.","date":"2014","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/25517973","citation_count":4,"is_preprint":false},{"pmid":"40055680","id":"PMC_40055680","title":"Mapping fatigue: discovering brain regions and genes linked to fatigue susceptibility.","date":"2025","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/40055680","citation_count":3,"is_preprint":false},{"pmid":"39808382","id":"PMC_39808382","title":"Novel Protective Role for Gut Microbiota-derived Metabolite PAGln in Doxorubicin-induced Cardiotoxicity.","date":"2025","source":"Cardiovascular drugs and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/39808382","citation_count":3,"is_preprint":false},{"pmid":"15969636","id":"PMC_15969636","title":"Characterization of endothelin-converting enzyme activities in ARPE-19 cells, a human retinal pigmented epithelial cell line.","date":"2005","source":"Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/15969636","citation_count":3,"is_preprint":false},{"pmid":"28557628","id":"PMC_28557628","title":"Identification of endothelin-converting enzyme-2 as an autoantigen in autoimmune polyendocrine syndrome type 1.","date":"2017","source":"Autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/28557628","citation_count":3,"is_preprint":false},{"pmid":"39955423","id":"PMC_39955423","title":"Identification of ECE2 signaling in promoting non-small lung cancer progression through ET1/YAP1/MAGEA3 axis.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/39955423","citation_count":2,"is_preprint":false},{"pmid":"2102652","id":"PMC_2102652","title":"Characterization of RD114-related endogenous cat retroviral elements ECE2.","date":"1990","source":"Archiv fur experimentelle Veterinarmedizin","url":"https://pubmed.ncbi.nlm.nih.gov/2102652","citation_count":1,"is_preprint":false},{"pmid":"37271044","id":"PMC_37271044","title":"Mutation analysis of the ECE1 gene in late-onset Alzheimer's disease.","date":"2023","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/37271044","citation_count":1,"is_preprint":false},{"pmid":"41205376","id":"PMC_41205376","title":"Endothelin-converting enzyme 2 regulates κ opioid receptor trafficking and function.","date":"2025","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/41205376","citation_count":0,"is_preprint":false},{"pmid":"39008339","id":"PMC_39008339","title":"Identification of potential differences in salivary proteomic profiles between estrus and diestrus stage of estrous cycle in dairy cows.","date":"2024","source":"Systems biology in reproductive medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39008339","citation_count":0,"is_preprint":false},{"pmid":"41099905","id":"PMC_41099905","title":"Exploring the evolutionary conservation and functional implications of Endothelin Converting Enzyme 1 (ECE1) in lamprey (Lethenteron reissneri).","date":"2025","source":"Fish physiology and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/41099905","citation_count":0,"is_preprint":false},{"pmid":"41741910","id":"PMC_41741910","title":"Lapatinib-Loaded Glucose-Functionalized Silver Nanoparticles Enhance Efficacy in HER2-Positive Breast Cancer Cells and Modulate Survival-Associated Genes.","date":"2026","source":"Pharmaceutical research","url":"https://pubmed.ncbi.nlm.nih.gov/41741910","citation_count":0,"is_preprint":false},{"pmid":"16191167","id":"PMC_16191167","title":"Histochemical distribution of endothelin-converting enzyme subtypes in Podarcis sicula (Squamata, Lacertidae) tissues.","date":"2005","source":"Journal of anatomy","url":"https://pubmed.ncbi.nlm.nih.gov/16191167","citation_count":0,"is_preprint":false},{"pmid":"20432672","id":"PMC_20432672","title":"[Artificial endothelial cell. From stem cells to transdifferentiated endothelial cells].","date":"2009","source":"Anales de la Real Academia Nacional de Medicina","url":"https://pubmed.ncbi.nlm.nih.gov/20432672","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.03.11.642672","title":"Endothelin-converting enzyme 2 differentially regulates kappa opioid receptor trafficking and function","date":"2025-03-13","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.11.642672","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49269,"output_tokens":6383,"usd":0.121776,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15273,"output_tokens":5118,"usd":0.102157,"stage2_stop_reason":"end_turn"},"total_usd":0.223933,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"ECE-2 is a membrane-bound, phosphoramidon-sensitive zinc metalloprotease that converts big ET-1 to mature ET-1 by cleavage at Trp21-Val22, with an acidic pH optimum of 5.5 (in contrast to ECE-1's neutral optimum). It is inhibited by phosphoramidon (250-fold more sensitive than ECE-1) and FR901533 but not by thiorphan or captopril. Transfection experiments in CHO cells showed it converts endogenously synthesized big ET-1 intracellularly but not exogenous big ET-1, indicating it acts as an intracellular enzyme in the trans-Golgi network.\",\n      \"method\": \"In vitro enzymatic assay, inhibitor profiling, transfected CHO cell functional assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro biochemical reconstitution plus cell-based functional assay with pharmacological inhibitors; foundational characterization paper replicated by multiple subsequent studies\",\n      \"pmids\": [\"7797512\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"ECE-2 knockout mice develop normally and are fertile, but when bred into an ECE-1 null background, cardiac outflow defects are more severe than in ECE-1 single knockouts, and ECE-1−/−;ECE-2−/− double-null embryos exhibit abnormal atrioventricular valve formation not seen in ECE-1 single knockouts. ECE-2 mRNA is expressed in endocardial cushion mesenchyme from E12.5. Together, this establishes ECE-2 has a role in murine cardiac development, particularly in endocardial cushion/valve formation.\",\n      \"method\": \"Homologous recombination knockout mice, genetic epistasis (double knockout), in situ hybridization, ET-1/ET-2 peptide measurement by immunoassay\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic KO with defined cardiac phenotype, double-mutant epistasis, replicated across multiple embryonic timepoints in a single rigorous study\",\n      \"pmids\": [\"10811845\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"ECE-2 deficient mice show significant increases in both Aβ40 and Aβ42 levels in the brain compared to age-matched littermate controls, providing the first direct in vivo evidence that ECE-2 physiologically limits Aβ accumulation in the brain.\",\n      \"method\": \"ECE-2 knockout mouse model, brain Aβ measurement by ELISA/immunoassay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean knockout mouse with specific biochemical readout (Aβ levels), directly establishing physiological role in Aβ clearance\",\n      \"pmids\": [\"12464614\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Purified recombinant ECE-2 cleaves big ET-1 to ET-1 at Trp21-Val22 at acidic pH and processes a panel of 42 neuropeptides at non-classical (non-basic residue) sites, preferring aliphatic/aromatic residues in the P1' position. ECE-2 processes proenkephalin-derived peptides (bovine adrenal medulla peptides) and PEN-LEN (an endogenous inhibitor of prohormone convertase 1) into products with altered biological activity, indicating a role in non-classical neuropeptide processing.\",\n      \"method\": \"Purification of recombinant ECE-2, mass spectrometry-based substrate profiling with 42-peptide panel, in vitro enzymatic assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — purified recombinant enzyme reconstitution with mass spectrometry substrate profiling and multiple peptide substrates; rigorous biochemical characterization\",\n      \"pmids\": [\"12560336\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"ECE-2 is localized intracellularly (not on the cell surface) in human umbilical vein endothelial cells. Using sucrose density gradient fractionation and pH/inhibitor profiling (sensitivity to 0.1 µM phosphoramidon at pH 5.4, IC50 1.5 nM; insensitive to ECE-1-selective inhibitor PD159790 at pH 5.4), ECE-2 activity was identified in intracellular fractions. Confocal microscopy showed punctate cytosolic staining consistent with secretory vesicles, suggesting a role in processing big ET-1 in transit via the constitutive secretory pathway.\",\n      \"method\": \"Subcellular fractionation (sucrose density gradient), pH-dependent enzymatic activity assay with selective inhibitors, confocal immunocytochemistry\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two orthogonal methods (biochemical fractionation + confocal microscopy) in a single study definitively establishing intracellular localization\",\n      \"pmids\": [\"10222335\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Four ECE-2 sub-isoforms (ECE-2a-1, ECE-2a-2, ECE-2b-1, ECE-2b-2) were identified that differ in their N-terminal cytoplasmic tails. RT-PCR showed strikingly different tissue distributions: ECE-2a-1 and ECE-2a-2 are expressed in liver, kidney, adrenal gland, testis, and endothelial cells, while ECE-2b-1 and ECE-2b-2 are enriched in brain and adrenal gland. Immunohistochemical analysis of CHO cells stably expressing ECE-2a-1 or ECE-2b-2 showed both isoforms localize to intracellular compartments, not the cell surface.\",\n      \"method\": \"RT-PCR, stable transfection of CHO cells, immunohistochemistry\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — single lab with two orthogonal methods (RT-PCR + immunohistochemistry), identifying isoform diversity and intracellular localization\",\n      \"pmids\": [\"12054617\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"ECE-2 knockout mice show normal physical appearance and motor behavior but display significant deficits in learning and memory, including impaired performance in the Morris water maze, deficits in object recognition and location memory, and impaired social transmission of food preference. This establishes ECE-2 as required for normal learning and memory function in vivo.\",\n      \"method\": \"ECE-2 knockout mice, Morris water maze, novel object recognition, social transmission of food preference behavioral assays\",\n      \"journal\": \"Genes, brain, and behavior\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean knockout mouse model with multiple independent behavioral readouts across different memory paradigms\",\n      \"pmids\": [\"21450041\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"ECE-2 homology model based on neprilysin crystal structure was generated, and site-directed mutagenesis identified that Tyr563 in the catalytic site significantly affects catalytic activity and inhibitor binding, while Trp148 mutation had lesser effect. Virtual screening of 13,000 compounds using the model identified three compounds with high affinity and specificity for ECE-2 over neprilysin.\",\n      \"method\": \"Homology modeling using neprilysin crystal structure as template, site-directed mutagenesis, virtual screening, in vitro enzymatic inhibition assays\",\n      \"journal\": \"Journal of medicinal chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — structure-based model with mutagenesis validation of active-site residues and functional confirmation via inhibitor assays; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"18507370\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ECE-2 co-localizes with markers of the endosomal/lysosomal pathway (but not with a trans-Golgi network marker) and is detected in autophagic vesicles. Pharmacological inhibition of ECE activity in SH-SY5Y cells overexpressing APP leads to intracellular Aβ accumulation specifically in the endosomal-autophagic-lysosomal compartments. ECE-2 regulates mainly the intracellular pool of Aβ (produced and degraded within the endosomal-autophagic-lysosomal pathways), distinct from ECE-1 which regulates both intracellular and secreted Aβ pools.\",\n      \"method\": \"Co-localization immunofluorescence microscopy, pharmacological ECE inhibition in APP-overexpressing SH-SY5Y cells, Aβ measurement by ELISA\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (subcellular co-localization + pharmacological inhibition + biochemical Aβ quantification) establishing compartment-specific function\",\n      \"pmids\": [\"23283972\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ECE-2 inhibition with the selective inhibitor S136492 impairs µ opioid receptor recycling and resensitization specifically for ligands that are ECE2 substrates (endogenous opioid peptides), both in heterologous cells and cells endogenously co-expressing µ receptors with ECE2. In vivo, ECE2 inhibition attenuated antinociception mediated only by ECE2-substrate opioid peptides (intrathecal tail-flick assay). This establishes ECE2 as modulating µ opioid receptor function through post-endocytic processing of peptide agonists.\",\n      \"method\": \"Selective pharmacological ECE2 inhibition, µ opioid receptor trafficking assay (ELISA and microscopy), cAMP signaling assay, in vivo tail-flick antinociception assay\",\n      \"journal\": \"British journal of pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (receptor trafficking, cAMP signaling, in vivo behavioral assay) with selective inhibitor and substrate-specificity controls; single lab\",\n      \"pmids\": [\"24990314\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ECE2 inhibition with selective inhibitors impairs δ opioid receptor recycling by protecting endocytosed peptide agonists from degradation, leading to decreased surface receptor signaling. ECE2 co-localizes intracellularly with δ opioid receptors following agonist treatment. In primary neurons, ECE2 inhibitor treatment increased intracellular co-localization of receptors with ECE2 and decreased recycling and surface receptor signaling.\",\n      \"method\": \"Selective ECE2 inhibitor treatment, δ opioid receptor trafficking assay (microscopy), intracellular peptide degradation assay (thin-layer chromatography), primary neuronal cultures\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods in heterologous and primary neurons establishing post-endocytic peptide processing as mechanism for receptor regulation\",\n      \"pmids\": [\"24847082\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"An ECE-2-specific fluorogenic substrate (PL405; Ac-SKG-Pya-F-W-Nop-GGK-NH2) was identified; ECE-2 cleaves PL405 at the Pya-F amide bond with kcat/Km = 8.1 × 10³ M⁻¹ s⁻¹. The first potent and selective ECE-2 inhibitor was characterized (Ki = 7.7 nM). The assay was validated using wild-type and ECE-2 knockout tissues ex vivo, confirming it reflects ECE-2 expression patterns.\",\n      \"method\": \"Fluorogenic substrate screening (Fluofast library), in vitro enzymatic kinetics, ECE-2 knockout tissue validation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with kinetic characterization and knockout tissue validation as orthogonal control; rigorous biochemical characterization\",\n      \"pmids\": [\"20807771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ECE-2 knockout mice show decreased antinociceptive response to a single morphine injection and more rapid development of tolerance with prolonged morphine treatment and fewer signs of naloxone-precipitated withdrawal. Peptidomic analysis of spinal cord revealed altered levels of multiple neuropeptides in ECE-2 KO mice compared to wild-type, consistent with ECE-2's role in non-classical in vivo spinal cord neuropeptide processing.\",\n      \"method\": \"ECE-2 knockout mice, hot-plate and tail-flick pain assays, naloxone-precipitated withdrawal, peptidomic mass spectrometry of spinal cord\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean knockout model with multiple behavioral readouts and peptidomic biochemical analysis establishing in vivo role in neuropeptide processing and morphine responses\",\n      \"pmids\": [\"21972895\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"ECE-2 is expressed predominantly in somatostatin-expressing GABAergic interneurons in hippocampus and neocortex (unlike ECE-1, which has broader distribution, and NEP, found in parvalbumin interneurons). ECE-2 was active in isolated synaptosomes, establishing that ECE-2 can degrade Aβ at inhibitory synapses relevant to Alzheimer's disease.\",\n      \"method\": \"In situ hybridization, immunohistochemistry with cell-type markers, synaptosome isolation and enzymatic activity assay\",\n      \"journal\": \"Neurobiology of aging\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (ISH, IHC with cell-type markers, functional synaptosome assay) definitively establishing cell-type-specific localization and activity\",\n      \"pmids\": [\"27644077\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ECE-1 and ECE-2 cleave and degrade α-synuclein in vitro. siRNA knockdown of ECE-1 or ECE-2 in SH-SY5Y cells significantly increased α-syn both intracellularly and extracellularly. ECE-2 co-localizes with α-syn within the endolysosomal system (confirmed by proximity ligation assay). ECE-2 levels are significantly reduced in postmortem cingulate cortex of dementia with Lewy bodies (DLB) patients and inversely correlate with severity of Lewy body pathology (α-syn phosphorylated at Ser129).\",\n      \"method\": \"In vitro enzymatic cleavage assay, siRNA knockdown, double immunofluorescence, proximity ligation assay, sandwich ELISA on postmortem tissue\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (in vitro assay, siRNA KD, co-localization, PLA, human tissue quantification) establishing ECE-2 as an α-syn degrading enzyme\",\n      \"pmids\": [\"28171705\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CRISPR-mediated inactivation of ECE2 (the synthetic enzyme for EDN3) from the zebrafish microenvironment abrogates melanoma phenotype switching from invasive/MITF-low to proliferative/MITF-high state following extravasation, and increases animal survival. This establishes ECE2 as required for microenvironment-driven endothelin-3 production that promotes melanoma metastatic plasticity.\",\n      \"method\": \"CRISPR-mediated gene inactivation in zebrafish, live zebrafish imaging, melanoma phenotype switching assay\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — CRISPR loss-of-function with defined phenotypic readout (phenotype switching, survival) in an in vivo vertebrate model\",\n      \"pmids\": [\"28181494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Zebrafish karneol (kar) mutant, defective in ece2, displays reduced iridophore numbers and defects in adult pigment stripe patterning. Morpholino knockdown identified Endothelin 3b (Edn3b) as the ligand for endothelin receptor signaling in larval iridophores processed by Ece2, establishing that Ece2-mediated proteolytic activation of endothelin ligands is required for iridophore development and melanophore maintenance in zebrafish.\",\n      \"method\": \"Zebrafish forward genetics (kar mutant), morpholino-mediated knockdown, genetic rescue\",\n      \"journal\": \"Biology open\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo genetic loss-of-function (mutant + morpholino) with defined cellular phenotype, identifying substrate ligand\",\n      \"pmids\": [\"24857848\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"ECE2 rare coding variants (R186C and F751S) located in the peptidase domain severely impair ECE2 enzymatic activity in Aβ degradation. Overexpression of wild-type ECE2 in the hippocampus of APP-knockin AD model mice reduced amyloid load, plaque formation, and improved learning and memory deficits, but the R186C mutant abolished these effects, directly linking ECE2 catalytic activity to Aβ clearance and AD-relevant phenotypes in vivo.\",\n      \"method\": \"Rare variant identification, in vitro enzymatic activity assay with Aβ substrate, stereotaxic AAV-mediated ECE2/R186C overexpression in APP-knockin mice, amyloid quantification, Morris water maze\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — mutagenesis establishing catalytic residue requirement, complemented by in vivo gene therapy with wild-type vs. mutant rescue in AD model mice\",\n      \"pmids\": [\"32102983\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Manipulation of ECE2 levels in human cerebral organoids and in the developing mouse cortex leads to ectopic localization of neural progenitors and neurons. ECE2 is required for normal neurogenesis and neuronal migration during cortical development, and mechanistically is involved in the generation and secretion of extracellular matrix proteins as well as cytoskeleton and adhesion processes. Biallelic ECE2 variants were identified in patients with periventricular heterotopia.\",\n      \"method\": \"Human cerebral organoids (ECE2 manipulation), in utero electroporation in developing mouse cortex, proteomic/secretome analysis, immunostaining for ECE2\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function in two independent experimental systems (organoids + mouse cortex) with defined cellular phenotype and mechanistic follow-up (ECM proteins, cytoskeleton)\",\n      \"pmids\": [\"32207244\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"ECE2 and κ opioid receptor (KOR) are in close proximity (demonstrated by proximity ligation assay) and co-internalize following activation by prodynorphin/proenkephalin-derived peptide substrates. ECE2 inhibition significantly attenuates KOR recycling and resensitization specifically for peptides that are ECE2 substrates but not for non-substrate peptides, establishing that ECE2 post-endocytically processes opioid peptides to regulate KOR trafficking and signaling.\",\n      \"method\": \"Proximity ligation assay, receptor internalization/recycling assay in recombinant and endogenously expressing cells, small molecule ECE2 inhibitor, cAMP signaling assay\",\n      \"journal\": \"The Journal of pharmacology and experimental therapeutics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (PLA, trafficking assays, signaling assays) in recombinant and endogenous cell systems with substrate-specificity controls; single lab\",\n      \"pmids\": [\"41205376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"ECE-2 mRNA and protein are markedly elevated in postmortem temporal cortex in Alzheimer's disease (AD) but not in vascular dementia. Exposure of SH-SY5Y cells to monomeric or oligomeric Aβ(1-42) caused an initial decrease in ECE-2 mRNA at 4 hours followed by a marked increase by 24 hours, demonstrating that Aβ42 upregulates ECE-2 expression.\",\n      \"method\": \"Quantitative real-time PCR, sandwich ELISA on postmortem brain tissue, Aβ42 treatment of SH-SY5Y cells with ECE-2 mRNA measurement\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — postmortem tissue quantification and in vitro stimulation assay; two methods but no direct mechanistic pathway dissection\",\n      \"pmids\": [\"19541930\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"ECE-1, but not ECE-2, cleaved somatostatin-14 (SST-14) in an acidic endosomal environment; ECE-2 did not hydrolyze SST-14 or octreotide. This negative result establishes substrate specificity boundaries: SST-14 is not an ECE-2 substrate.\",\n      \"method\": \"Pharmacological inhibition of ECE-1 with SM-19712, bafilomycin A1 to prevent endosomal acidification, radiolabeled substrate degradation assay\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single lab with direct in vitro substrate assay; this is a negative result establishing substrate specificity\",\n      \"pmids\": [\"18276747\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ECE-2 is an intracellularly localized (trans-Golgi/endosomal-lysosomal compartments), acidic pH-optimum (pH 5.5), phosphoramidon-sensitive zinc metalloprotease of the M13/neprilysin family that converts big endothelin to ET-1 intracellularly, processes neuropeptides at non-classical cleavage sites, degrades Aβ peptide and α-synuclein within endosomal-autophagic-lysosomal pathways, and regulates µ, δ, and κ opioid receptor recycling and resensitization by post-endocytic hydrolysis of co-internalized peptide agonists; it is also required for normal cardiac development, neuronal migration/neurogenesis in the cortex, learning and memory, and spinal cord neuropeptide homeostasis, with its Aβ-degrading catalytic activity directly linked to Alzheimer's disease risk.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ECE2 is an intracellular, acidic-pH-optimum (pH 5.5), phosphoramidon-sensitive zinc metalloprotease of the neprilysin-related family that processes endothelin precursors and a broad set of neuropeptides at non-classical cleavage sites within secretory and endolysosomal compartments [#0, #3, #4]. It converts big ET-1 to mature ET-1 by cleavage at Trp21-Val22 intracellularly rather than at the cell surface, and exists as multiple N-terminally distinct sub-isoforms with tissue-specific distributions that all localize to intracellular compartments [#0, #4, #5]. A neprilysin-based homology model and site-directed mutagenesis identify Tyr563 as a catalytic-site residue critical for activity and inhibitor binding [#7]. ECE2 resides in endosomal/lysosomal and autophagic vesicles, where it degrades intracellular pools of the amyloid-\\u03b2 peptide and \\u03b1-synuclein; loss of ECE2 raises brain A\\u03b240 and A\\u03b242 and elevates \\u03b1-synuclein, and ECE2 is dysregulated in Alzheimer's disease and dementia-with-Lewy-bodies brain tissue [#2, #8, #14, #20]. In the nervous system ECE2 is enriched in somatostatin-expressing GABAergic interneurons and acts at synapses, shaping spinal-cord neuropeptide content and supporting learning and memory [#6, #12, #13]. Through post-endocytic hydrolysis of co-internalized peptide agonists, ECE2 regulates the recycling and resensitization of \\u00b5, \\u03b4, and \\u03ba opioid receptors in a substrate-specific manner, influencing opioid antinociception and morphine tolerance in vivo [#9, #10, #12, #19]. ECE2 is also required for endothelin-ligand activation driving cardiac endocardial cushion/valve development, pigment-cell development, melanoma phenotype switching, and cortical neurogenesis and neuronal migration, the last linked to periventricular heterotopia caused by biallelic ECE2 variants [#1, #15, #16, #18]. Rare peptidase-domain coding variants that impair A\\u03b2-degrading activity, together with rescue of amyloid load and memory deficits by wild-type but not catalytically defective ECE2 in AD model mice, directly link ECE2 catalytic activity to Alzheimer's disease risk [#17].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established ECE2 as a distinct endothelin-converting enzyme by showing it cleaves big ET-1 to ET-1 with an acidic pH optimum and acts intracellularly, distinguishing it from the neutral-pH, surface-acting ECE-1.\",\n      \"evidence\": \"In vitro enzymatic assay with inhibitor profiling and transfected CHO cell functional assay\",\n      \"pmids\": [\"7797512\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the physiological compartment beyond trans-Golgi inference\", \"Full substrate repertoire beyond big ET-1 unknown at this stage\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Resolved where ECE2 acts by demonstrating it is intracellular rather than cell-surface, supporting a role in processing big ET-1 in transit through the secretory pathway.\",\n      \"evidence\": \"Sucrose-gradient subcellular fractionation, pH/inhibitor activity profiling, and confocal immunocytochemistry in HUVECs\",\n      \"pmids\": [\"10222335\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not distinguish secretory vesicle from endosomal/lysosomal residence\", \"Did not address non-endothelin substrates\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Defined an in vivo developmental role by showing ECE2 contributes to cardiac endocardial cushion and valve formation, unmasked in the ECE-1 null background.\",\n      \"evidence\": \"Single and double knockout mice with genetic epistasis, in situ hybridization, and ET peptide immunoassay\",\n      \"pmids\": [\"10811845\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"ECE2 single knockouts are normal, leaving its independent requirement unclear\", \"Molecular substrate driving the valve phenotype not pinpointed\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Extended ECE2 function beyond endothelins by showing it physiologically limits brain A\\u03b2 accumulation and exists as tissue-specific sub-isoforms.\",\n      \"evidence\": \"Knockout mouse brain A\\u03b2 ELISA; RT-PCR and immunohistochemistry of isoforms in transfected cells\",\n      \"pmids\": [\"12464614\", \"12054617\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct enzymatic degradation of A\\u03b2 not yet shown\", \"Functional consequence of isoform diversity unresolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Characterized ECE2 as a non-classical neuropeptide-processing protease, cleaving at aliphatic/aromatic P1' residues across a 42-peptide panel including enkephalin-derived peptides and PEN-LEN.\",\n      \"evidence\": \"Purified recombinant enzyme with mass spectrometry-based substrate profiling\",\n      \"pmids\": [\"12560336\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which substrates are processed in vivo not established\", \"Biological significance of altered peptide products not tested\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Provided a structural and behavioral framework: an active-site model identified Tyr563 as catalytically important and selective inhibitors were derived, while knockout mice revealed learning and memory deficits; substrate boundaries were refined by showing somatostatin-14 is not a substrate.\",\n      \"evidence\": \"Neprilysin-based homology modeling with mutagenesis and virtual screening; behavioral testing of knockout mice; in vitro substrate assays with bafilomycin/SM-19712\",\n      \"pmids\": [\"18507370\", \"21450041\", \"18276747\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No experimental crystal structure of ECE2\", \"Molecular substrate linking ECE2 to memory not identified\", \"SST-14 negative result limited to in vitro conditions\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Built a selective toolkit by identifying an ECE2-specific fluorogenic substrate and a potent selective inhibitor, validated against knockout tissue.\",\n      \"evidence\": \"Fluorogenic substrate screening with kinetic characterization and ECE2 knockout tissue validation\",\n      \"pmids\": [\"20807771\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Synthetic substrate does not identify endogenous physiological substrates\", \"Inhibitor specificity in complex tissue not exhaustively profiled\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Connected ECE2 to opioid pharmacology and in vivo neuropeptide homeostasis by showing knockouts have altered morphine responses and a shifted spinal-cord peptidome.\",\n      \"evidence\": \"Knockout mice with pain/tolerance/withdrawal assays and spinal-cord peptidomic mass spectrometry\",\n      \"pmids\": [\"21972895\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Causal peptide substrates underlying morphine phenotypes not isolated\", \"Did not separate direct opioid-peptide processing from broader peptidome changes\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Refined ECE2's compartment to the endosomal-autophagic-lysosomal system, establishing it controls the intracellular A\\u03b2 pool distinct from ECE-1's broader action.\",\n      \"evidence\": \"Co-localization microscopy and pharmacological ECE inhibition in APP-overexpressing SH-SY5Y cells with A\\u03b2 ELISA\",\n      \"pmids\": [\"23283972\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Pharmacological inhibition does not isolate ECE2 from ECE-1\", \"Mechanism of A\\u03b2 entry into the degradative compartment not defined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Defined the mechanism of opioid receptor regulation as post-endocytic hydrolysis of co-internalized peptide agonists, controlling \\u00b5 and \\u03b4 receptor recycling and resensitization in a substrate-specific manner.\",\n      \"evidence\": \"Selective ECE2 inhibitors, receptor trafficking and cAMP assays, intracellular peptide degradation assays, primary neurons, and in vivo antinociception\",\n      \"pmids\": [\"24990314\", \"24847082\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relied on pharmacological inhibition rather than genetic ablation in trafficking assays\", \"Structural basis of ECE2-receptor proximity not resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established that ECE2-mediated endothelin-ligand activation is required for pigment-cell development, identifying Edn3b as a processed ligand.\",\n      \"evidence\": \"Zebrafish forward genetics (kar mutant), morpholino knockdown, and genetic rescue\",\n      \"pmids\": [\"24857848\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct biochemical cleavage of Edn3b by Ece2 not shown in this system\", \"Relevance to mammalian pigment biology not addressed\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Pinpointed the cellular source of ECE2 in the brain to somatostatin-expressing GABAergic interneurons and showed it is active at synapses, defining a cell-type context for A\\u03b2 degradation.\",\n      \"evidence\": \"In situ hybridization, cell-type-marker immunohistochemistry, and synaptosome enzymatic activity assays\",\n      \"pmids\": [\"27644077\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of interneuron-specific A\\u03b2 degradation not tested\", \"Did not establish synaptic substrate specificity\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Broadened ECE2's degradative role to \\u03b1-synuclein within the endolysosomal system and linked reduced ECE2 to Lewy body pathology; in cancer, ECE2-driven endothelin-3 production was shown to enable melanoma phenotype switching and metastasis.\",\n      \"evidence\": \"In vitro cleavage, siRNA knockdown, PLA co-localization, and postmortem ELISA for \\u03b1-syn; CRISPR inactivation with live imaging in zebrafish melanoma\",\n      \"pmids\": [\"28171705\", \"28181494\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ECE2 loss is cause or consequence of DLB pathology unresolved\", \"Direct endothelin substrate in melanoma microenvironment not biochemically isolated\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Causally tied ECE2 catalytic activity to Alzheimer's disease and identified a developmental neuronal-migration role, providing direct genetic links to human disease.\",\n      \"evidence\": \"Rare-variant identification with enzymatic assays and AAV wild-type vs. R186C rescue in APP-knockin mice; ECE2 manipulation in cerebral organoids and in utero electroporation with secretome proteomics, plus biallelic variants in periventricular heterotopia\",\n      \"pmids\": [\"32102983\", \"32207244\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking ECM/cytoskeleton effects to migration not fully dissected\", \"Penetrance and full genetic spectrum of human variants not defined\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Completed the opioid receptor regulatory model by showing ECE2 also controls \\u03ba opioid receptor trafficking through substrate-specific post-endocytic peptide processing.\",\n      \"evidence\": \"Proximity ligation assay, receptor internalization/recycling and cAMP assays with substrate-specificity controls in recombinant and endogenous cells\",\n      \"pmids\": [\"41205376\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Single-lab pharmacological approach without genetic confirmation\", \"In vivo consequences of KOR regulation not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How ECE2's distinct functions \\u2014 endothelin maturation, neuropeptide processing, A\\u03b2/\\u03b1-synuclein degradation, opioid receptor regulation, and cortical development \\u2014 are partitioned across its sub-isoforms and subcellular compartments, and which substrates drive each in vivo phenotype, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No experimental structure of ECE2\", \"Isoform-specific functional assignments not established\", \"Substrate-to-phenotype causality not mapped for most in vivo roles\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 3, 7, 11, 14, 17]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 3, 17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [8, 10, 14]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [8, 14]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [0, 4]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [4, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 3, 17]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [9, 10, 19]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [1, 16, 18]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [2, 14, 17]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"OPRM1\", \"OPRD1\", \"OPRK1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}